Clinical trials of the first drugs designed with the help of artificial intelligence could commence this year, Google DeepMind CEO Demis Hassabis suggested Tuesday. Speaking on a panel at the World ...

It’s true to say that drug usage has a variety of negative consequences for its users and, on the whole, governments are right to advise against it. People in New York who smoke cannabis should ...

A non-opioid investigational drug with promising pre-clinical results in treating neuropathic pain has passed an important hurdle after the study's safety review committee (SRC) reviewed the data from ...

2025 will be no exception to this rule, and with its arrival we examine FDA’s activities in 2024 in the drug development ... new uses of approved drugs or investigational drugs with an ...

Some of China’s senior doctors are raising concern over the quality of domestic generic medicines that have largely replaced western brand-name drugs at hospitals, amid a rare public backlash ...

Blockbuster obesity drugs such as Ozempic have been celebrated for their ability to promote weight loss and treat a surprising range of other conditions, from heart problems to Parkinson’s disease.

Minovacca plans to hire Nebraska students whose work will drive the company toward a major milestone: submitting an Investigational New Drug Application to the U.S. Food and Drug Administration ...

The investigational drug, called PMD-026, is currently in phase 2 clinical trials for the treatment of breast cancer. Researchers at Washington University School of Medicine in St. Louis, MO, have ...

The investigational drug PMD-026 is a pan-RSK inhibitor in that it blocks all four versions of the protein -- RSK1, RSK2, RSK3 and RSK4. In breast cancer, the evidence suggests that PMD-026 may ...

The drug’s safety profile in this specific patient population will also be established. “The trial will be using state-of-the art, continuous measurements of nighttime BP to generate thousands ...

Drugmakers raised the list prices on 575 name-brand drugs in just the first two days of the new year, according to drug price research firm 46brooklyn. Drugs for diabetes, HIV, cancer saw price ...